Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer

The goal of this study was to identify a novel target for antibody-drug conjugate (ADC) development in triple negative breast cancer (TNBC), which has limited treatment options, using gene expression datasets and in vitro siRNA/CRISPR and in vivo functional assays. We analyzed 4467 breast cancers an...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Wali, Vikram B., Patwardhan, Gauri A., Pelekanou, Vasiliki, Karn, Thomas, Cao, Jian, Ocana, Alberto, Yan, Qin, Nelson, Bryce, Hatzis, Christos, Pusztai, Lajos
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6797726/
https://ncbi.nlm.nih.gov/pubmed/31624295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-51453-w
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia